NTRK1 and cancer: In the second study, pan-TRK IHC was less effective in detecting fusions involving NTRK3, which may reduce the overall sensitivity of IHC as the ETV6-NTRK3 fusions has been reported as the most common TRK fusion in pan-cancer studies [33, 81].